Prix Galien USA Honors Innovation in Science and Biotech NEW YORK (October 1, 2009) - The Prix Galien USA committee celebrated members of science and biotechnology on September 30th for the development and discovery of drugs and technologies that improve the human condition. Novartis Oncology, Amgen, GlaxoSmithKline and Veridex were honored with the 2009 Prix Galien USA, considered the industry's highest accolade for pharmaceutical research and development, for treatments that could change the course of health care worldwide. READ FULL RELEASE